Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hepsin regulates TGFβ signaling via fibronectin proteolysis
Denis Belitškin, Shishir M. Pant, Pauliina Munne, et al.
EMBO Reports (2021) Vol. 22, Iss. 11
Open Access | Times Cited: 14

Showing 14 citing articles:

TGF-β, EMT, and resistance to anti-cancer treatment
Xuecong Wang, Pieter J.A. Eichhorn, Jean Paul Thiery
Seminars in Cancer Biology (2023) Vol. 97, pp. 1-11
Open Access | Times Cited: 53
Extracellular proteolysis in cancer: Proteases, substrates, and mechanisms in tumor progression and metastasis
Evette S. Radisky
Journal of Biological Chemistry (2024) Vol. 300, Iss. 6, pp. 107347-107347
Open Access | Times Cited: 24
Inhibition of the extracellular enzyme A disintegrin and metalloprotease with thrombospondin motif 4 prevents cardiac fibrosis and dysfunction
Maria Vistnes, Pugazendhi M Erusappan, Athiramol Sasi, et al.
Cardiovascular Research (2023) Vol. 119, Iss. 10, pp. 1915-1927
Open Access | Times Cited: 12
Inhibiting fibronectin assembly in the breast tumor microenvironment increases cell death and improves response to doxorubicin
Metti K. Gari, Hyejin Lee, David R. Inman, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
TGF-β Signaling Pathway-Based Model to Predict the Subtype and Prognosis of Head and Neck Squamous Cell Carcinoma
Lian Zheng, Zhenjie Guan, Miaomiao Xue
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 15
Type II Transmembrane Serine Proteases as Modulators in Adipose Tissue Phenotype and Function
Qingyu Wu, Shuo Li, Xianrui Zhang, et al.
Biomedicines (2023) Vol. 11, Iss. 7, pp. 1794-1794
Open Access | Times Cited: 7
Remodeling of the extracellular matrix by serine proteases as a prerequisite for cancer initiation and progression
Tomasz Wenta, Paulina Nastały, Barbara Lipińska, et al.
Matrix Biology (2024) Vol. 134, pp. 197-219
Closed Access | Times Cited: 2
Spatial position is a key determinant of N‐glycan functionality of the scavenger receptor cysteine‐rich domain of human hepsin
Shijin Sun, Kaixuan Hu, Lina Wang, et al.
FEBS Journal (2023) Vol. 290, Iss. 16, pp. 3966-3982
Closed Access | Times Cited: 4
Baseline Values of Circulating IL-6 and TGF-β Might Identify Patients with HNSCC Who Do Not Benefit from Nivolumab Treatment
Marco Merlano, Matteo Paccagnella, Nerina Denaro, et al.
Cancers (2023) Vol. 15, Iss. 21, pp. 5257-5257
Open Access | Times Cited: 4
Hepsin promotes breast tumor growth signaling via the TGFβ‐EGFR axis
Denis Belitškin, Pauliina Munne, Shishir M. Pant, et al.
Molecular Oncology (2023) Vol. 18, Iss. 3, pp. 547-561
Open Access | Times Cited: 3
The POR rs10954732 polymorphism decreases susceptibility to hepatocellular carcinoma and hepsin as a prognostic biomarker correlated with immune infiltration based on proteomics
Yan Fang, Hongming Yang, Guiming Hu, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 5
A joint profile of cytokines and immune cell populations may identify HNSCC patients who benefit from nivolumab treatment. The Gruppo Oncologico Nord-Ovest (GONO) study Nivactor T-2
Marco Merlano, Matteo Paccagnella, Nerina Denaro, et al.
Research Square (Research Square) (2023)
Open Access
PERSPECTIVE OF FIBRIN CAPSULE IN INHIBITION OF GROWTH AND METASTASIS OF MALIGNANT TUMORS
Mariana Kuryk, Iryna Fomenko
Bulletin of Problems Biology and Medicine (2023) Vol. 1, Iss. 2, pp. 30-30
Open Access
Page 1

Scroll to top